
Saturday, June 15, 2024 11:03:50 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent TLSI News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/10/2025 11:47:21 AM
- TriSalus Reports Q3 2024 Financial Results and Provides Business Update • Business Wire • 11/14/2024 01:00:00 PM
- TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer • Business Wire • 11/11/2024 12:00:00 PM
- TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment • Business Wire • 11/07/2024 12:00:00 PM
- TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call • Business Wire • 10/31/2024 12:00:00 PM
- TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit • Business Wire • 10/14/2024 08:05:00 PM
- TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board • Business Wire • 09/26/2024 11:00:00 AM
- TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System • Business Wire • 09/23/2024 11:00:00 AM
- TriSalus Reports Q2 2024 Financial Results and Business Update • Business Wire • 08/15/2024 12:00:00 PM
- TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call • Business Wire • 08/01/2024 11:00:00 AM
- TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation • Business Wire • 07/01/2024 08:00:00 PM
- TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants • Business Wire • 06/26/2024 09:45:00 PM
- TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma at 2024 ASCO Annual Meeting • Business Wire • 06/03/2024 11:00:00 AM
- TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants • Business Wire • 05/24/2024 10:05:00 AM
- TriSalus Reports Q1 2024 Financial Results and Business Update • Business Wire • 05/15/2024 12:00:00 PM
- TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors • Business Wire • 05/07/2024 11:00:00 AM
- TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call • Business Wire • 05/06/2024 08:58:00 PM
- TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives • Business Wire • 04/30/2024 08:35:00 PM
- TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update • Business Wire • 04/01/2024 12:00:00 PM
- TriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific Meeting • Business Wire • 03/26/2024 12:00:00 PM
- TriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting • Business Wire • 03/21/2024 12:00:00 PM
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making • SIGY • Mar 12, 2025 9:41 AM